CYTK Cytokinetics Inc

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

$47.30  -1.62 (-3.31%)
As of 06/28/2022 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/29/2004
Outstanding shares:  85,652,213
Average volume:  797,418
Market cap:   $4,047,067,064
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BBBSBJ5
Valuation   (See tab for details)
PE ratio:   -15.71
PB ratio:   34.77
PS ratio:   62.24
Return on equity:   -221.62%
Net income %:   -396.22%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy